Director
DIN: 08585626
Jitendra Dnyandeo Wagh is currently associated with 2 companies in various capacities such as Director and Individual Promoter. They serve as a Director at GENEXIS BIOTECH PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 08585626.Jitendra Dnyandeo Wagh is currently involved in 2 different roles. Their most recent position is with GENEXIS PEPTIDES PRIVATE LIMITED as a Director. The first company Jitendra Dnyandeo Wagh was appointed to as a director was GENEXIS BIOTECH PRIVATE LIMITED. Jitendra Dnyandeo Wagh is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Jitendra Dnyandeo Wagh is currently associated with 2 companies in various capacities such as Director and Individual Promoter. They serve as a Director at GENEXIS BIOTECH PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 08585626.Jitendra Dnyandeo Wagh is currently involved in 2 different roles. Their most recent position is with GENEXIS PEPTIDES PRIVATE LIMITED as a Director. The first company Jitendra Dnyandeo Wagh was appointed to as a director was GENEXIS BIOTECH PRIVATE LIMITED. Jitendra Dnyandeo Wagh is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
4
Male
India
Call +91 81049 46419 and we'll pull the verified contact details for you.
Current Companies (2)
Current LLPs (0)
Past Companies (0)
1y 5m 9 Months Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| GENEXIS BIOTECH PRIVATE LIMITED | Director | 14-Oct-2019 |
| GENEXIS BIOTECH PRIVATE LIMITED | Individual Promoter | 14-Oct-2019 |
| GENEXIS PEPTIDES PRIVATE LIMITED | Director | 30-Dec-2022 |
| GENEXIS PEPTIDES PRIVATE LIMITED | Individual Promoter | 30-Dec-2022 |